Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200320554> ?p ?o ?g. }
- W3200320554 abstract "Mesenchymal stromal cells (MSCs) are a potential therapeutic tool for pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful immune responses or unknown pathogen infections in the recipients. Therefore, MSCs cultured in serum-free media (SF-MSCs) are ideal for clinical settings; however, their efficacy in pulmonary fibrosis is unknown. Here, we investigated the effects of SF-MSCs on bleomycin-induced pulmonary inflammation and fibrosis compared to those of MSCs cultured in serum-containing media (S-MSCs).SF-MSCs and S-MSCs were characterized in vitro using RNA sequence analysis. The in vivo kinetics and efficacy of SF-MSC therapy were investigated using a murine model of bleomycin-induced pulmonary fibrosis. For normally distributed data, Student's t test and one-way repeated measures analysis of variance followed by post hoc Tukey's test were used for comparison between two groups and multiple groups, respectively. For non-normally distributed data, Kruskal-Wallis and Mann-Whitney U tests were used for comparison between groups, using e Bonferroni's correction for multiple comparisons. All tests were two-sided, and P < 0.05 was considered statistically significant.Serum-free media promoted human bone marrow-derived MSC expansion and improved lung engraftment of intravenously administered MSCs in recipient mice. SF-MSCs inhibited the reduction in serum transforming growth factor-β1 and the increase of interleukin-6 in both the serum and the bronchoalveolar lavage fluid during bleomycin-induced pulmonary fibrosis. SF-MSC administration increased the numbers of regulatory T cells (Tregs) in the blood and lungs more strongly than in S-MSC administration. Furthermore, SF-MSCs demonstrated enhanced antifibrotic effects on bleomycin-induced pulmonary fibrosis, which were diminished by antibody-mediated Treg depletion.SF-MSCs significantly suppressed BLM-induced pulmonary inflammation and fibrosis through enhanced induction of Tregs into the lungs and corrected the dysregulated cytokine balance. Therefore, SF-MSCs could be a useful tool for preventing pulmonary fibrosis progression without the demerits of serum use." @default.
- W3200320554 created "2021-09-27" @default.
- W3200320554 creator A5000041318 @default.
- W3200320554 creator A5003535230 @default.
- W3200320554 creator A5011406390 @default.
- W3200320554 creator A5018609405 @default.
- W3200320554 creator A5019476442 @default.
- W3200320554 creator A5025425603 @default.
- W3200320554 creator A5035788546 @default.
- W3200320554 creator A5038228482 @default.
- W3200320554 creator A5045584729 @default.
- W3200320554 creator A5066014261 @default.
- W3200320554 creator A5069087687 @default.
- W3200320554 creator A5070616232 @default.
- W3200320554 creator A5074630814 @default.
- W3200320554 creator A5080945096 @default.
- W3200320554 date "2021-09-16" @default.
- W3200320554 modified "2023-10-16" @default.
- W3200320554 title "Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis" @default.
- W3200320554 cites W1550074279 @default.
- W3200320554 cites W1819517038 @default.
- W3200320554 cites W1845769873 @default.
- W3200320554 cites W1938547050 @default.
- W3200320554 cites W1977689261 @default.
- W3200320554 cites W1999061678 @default.
- W3200320554 cites W1999355929 @default.
- W3200320554 cites W2000115250 @default.
- W3200320554 cites W2008277917 @default.
- W3200320554 cites W2010916136 @default.
- W3200320554 cites W2021686032 @default.
- W3200320554 cites W2025371271 @default.
- W3200320554 cites W2037222483 @default.
- W3200320554 cites W2038399651 @default.
- W3200320554 cites W2045574035 @default.
- W3200320554 cites W2048835947 @default.
- W3200320554 cites W2058864165 @default.
- W3200320554 cites W2060928333 @default.
- W3200320554 cites W2065059030 @default.
- W3200320554 cites W2074445029 @default.
- W3200320554 cites W2081285252 @default.
- W3200320554 cites W2086194617 @default.
- W3200320554 cites W2091754993 @default.
- W3200320554 cites W2092810335 @default.
- W3200320554 cites W2153949260 @default.
- W3200320554 cites W2155779547 @default.
- W3200320554 cites W2166050879 @default.
- W3200320554 cites W2167383172 @default.
- W3200320554 cites W2167992899 @default.
- W3200320554 cites W2174299838 @default.
- W3200320554 cites W2336145754 @default.
- W3200320554 cites W2476927394 @default.
- W3200320554 cites W2551096367 @default.
- W3200320554 cites W2554615464 @default.
- W3200320554 cites W2564778420 @default.
- W3200320554 cites W2596348429 @default.
- W3200320554 cites W2610199736 @default.
- W3200320554 cites W2754468979 @default.
- W3200320554 cites W2766645546 @default.
- W3200320554 cites W2790194345 @default.
- W3200320554 cites W2806560654 @default.
- W3200320554 cites W2893132945 @default.
- W3200320554 cites W2965819160 @default.
- W3200320554 cites W2968261539 @default.
- W3200320554 cites W2981028433 @default.
- W3200320554 cites W2984614073 @default.
- W3200320554 cites W2990400671 @default.
- W3200320554 cites W2992079273 @default.
- W3200320554 cites W3006667419 @default.
- W3200320554 cites W3009125272 @default.
- W3200320554 cites W3013441061 @default.
- W3200320554 cites W3029242248 @default.
- W3200320554 cites W3037801207 @default.
- W3200320554 cites W3085830444 @default.
- W3200320554 cites W3120463228 @default.
- W3200320554 cites W3128772790 @default.
- W3200320554 cites W3135080097 @default.
- W3200320554 cites W3137007462 @default.
- W3200320554 cites W3156709835 @default.
- W3200320554 doi "https://doi.org/10.1186/s13287-021-02574-5" @default.
- W3200320554 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8444523" @default.
- W3200320554 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34530920" @default.
- W3200320554 hasPublicationYear "2021" @default.
- W3200320554 type Work @default.
- W3200320554 sameAs 3200320554 @default.
- W3200320554 citedByCount "5" @default.
- W3200320554 countsByYear W32003205542022 @default.
- W3200320554 countsByYear W32003205542023 @default.
- W3200320554 crossrefType "journal-article" @default.
- W3200320554 hasAuthorship W3200320554A5000041318 @default.
- W3200320554 hasAuthorship W3200320554A5003535230 @default.
- W3200320554 hasAuthorship W3200320554A5011406390 @default.
- W3200320554 hasAuthorship W3200320554A5018609405 @default.
- W3200320554 hasAuthorship W3200320554A5019476442 @default.
- W3200320554 hasAuthorship W3200320554A5025425603 @default.
- W3200320554 hasAuthorship W3200320554A5035788546 @default.
- W3200320554 hasAuthorship W3200320554A5038228482 @default.
- W3200320554 hasAuthorship W3200320554A5045584729 @default.
- W3200320554 hasAuthorship W3200320554A5066014261 @default.
- W3200320554 hasAuthorship W3200320554A5069087687 @default.
- W3200320554 hasAuthorship W3200320554A5070616232 @default.